Technical Analysis for ARWR - Arrowhead Research Corporation

Grade Last Price % Change Price Change
F 28.14 -0.50% -0.14
ARWR closed down 0.5 percent on Monday, March 18, 2024, on 80 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
3 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Slingshot Bearish Bearish Swing Setup -0.50%
Bullish Engulfing Bullish -0.50%
Stochastic Buy Signal Bullish -0.50%
Pocket Pivot Bullish Swing Setup -0.50%
Outside Day Range Expansion -0.50%
Wide Bands Range Expansion -0.50%
Oversold Stochastic Weakness -0.50%

   Recent Intraday Alerts

Alert Time
60 Minute Opening Range Breakout about 15 hours ago
Possible Inside Day about 16 hours ago
Down 3% about 20 hours ago
Down 2 % about 21 hours ago
Down 1% about 21 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Arrowhead Research Corporation Description

Arrowhead Research Corporation operates as a clinical stage therapeutics company. It has development programs in oncology, obesity, and chronic hepatitis B virus (HBV) infection. The company assembles a set of technologies, including Dynamic Polyconjugate platform, a RNA delivery system that addresses multiple organ systems and cell types, promotes multi-log gene knockdown in rodents and non-human primates, and induces endosomal escape; and RONDEL, a RNA delivery system for systemic siRNA delivery, and RNAi-mediated mRNA and protein knockdown in human melanoma patients. It also offers Homing Peptides platform, a library of short peptides for the development of peptide-drug conjugates and companion diagnostics. The company's principal product candidates include Adipotide, an anti-obesity peptide, which is in Phase I clinical trial for disrupting the blood supply that supports unhealthy fat by the targeted induction of apoptosis (cell death) in the vasculature of adipose tissue; ARC-520, an RNAi-based therapeutic to treat chronic HBV infection; and CALAA-01, an RNAi-based therapeutic that has completed a Phase IB clinical trial, which targets solid tumors. Its products also comprise CRLX-101 for NSC lung cancer; and Tubulin Inhibitor for oncology. The company, formerly known as InterActive Group, Inc., was founded in 2003 and is headquartered in Pasadena, California.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Solid Tumors Organ Systems Molecular Biology Infection Hepatitis B Gene Expression Obesity RNA Rna Interference Apoptosis Chronic Hepatitis B Virus Chronic Hbv Infection Si RNA Small Interfering Rna

Is ARWR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 42.48
52 Week Low 20.67
Average Volume 1,601,618
200-Day Moving Average 30.39
50-Day Moving Average 32.59
20-Day Moving Average 31.28
10-Day Moving Average 30.65
Average True Range 2.02
RSI (14) 40.48
ADX 22.5
+DI 15.84
-DI 26.71
Chandelier Exit (Long, 3 ATRs) 30.66
Chandelier Exit (Short, 3 ATRs) 33.06
Upper Bollinger Bands 36.60
Lower Bollinger Band 25.96
Percent B (%b) 0.2
BandWidth 34.01
MACD Line -0.92
MACD Signal Line -0.33
MACD Histogram -0.5894
Fundamentals Value
Market Cap 3.49 Billion
Num Shares 124 Million
EPS -2.77
Price-to-Earnings (P/E) Ratio -10.16
Price-to-Sales 21.99
Price-to-Book 25.15
PEG Ratio -1.32
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 29.87
Resistance 3 (R3) 29.75 29.05 29.58
Resistance 2 (R2) 29.05 28.61 29.11 29.48
Resistance 1 (R1) 28.60 28.34 28.25 28.72 29.39
Pivot Point 27.90 27.90 27.73 27.96 27.90
Support 1 (S1) 27.45 27.46 27.10 27.57 26.89
Support 2 (S2) 26.75 27.19 26.81 26.80
Support 3 (S3) 26.30 26.75 26.70
Support 4 (S4) 26.42